Jasper Therapeutics, Inc. Common Stock (NASDAQ: JSPR) last traded at $0.501, up 1.09% on the session. The quote above updates while this page is open; the figures below are drawn from Jasper Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Jasper Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker JSPR. Its market capitalisation is $16.67 million.
Valuation measures for Jasper Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $16.67M |
|---|---|
| Enterprise value | $19.75M |
| Price / book | 11.80 |
| Beta | 1.76 |
Trailing-twelve-month figures tagged in Jasper Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$31.77M |
| EPS (TTM) | -$0.940 |
|---|
| Return on equity | -2248.48% |
|---|
| Cash | $7.31M |
|---|
Range and volume for JSPR over the past 52 weeks.
| 52-week high | $2.69 |
|---|---|
| 52-week low | $0.315 |
| Volume | 620.1K |
| Average volume | 1.28M |
| Previous close | $0.496 |
Invest a chosen dollar amount in Jasper Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell JSPR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.